US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.900
  • +0.120+3.17%
Close Aug 23 16:00 ET
  • 3.900
  • 0.0000.00%
Post 16:02 ET
329.25MMarket Cap-1857P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
33.15%46.92M
67.93%69.81M
25.65%164.16M
16.73%46.57M
150.51%40.79M
9.10%35.24M
-1.44%41.57M
-38.66%130.65M
-43.80%39.9M
-70.38%16.28M
Selling and administrative expenses
-7.23%12.22M
-3.04%12.23M
2.47%49.92M
-6.72%11.53M
10.79%12.6M
5.91%13.17M
0.58%12.62M
6.40%48.71M
-6.29%12.36M
-4.72%11.38M
-General and administrative expense
-7.23%12.22M
-3.04%12.23M
2.47%49.92M
-6.72%11.53M
10.79%12.6M
5.91%13.17M
0.58%12.62M
6.40%48.71M
-6.29%12.36M
-4.72%11.38M
Research and development costs
57.26%34.7M
98.85%57.58M
39.43%114.24M
27.25%35.05M
474.54%28.18M
11.10%22.06M
-2.29%28.95M
-51.00%81.94M
-52.36%27.54M
-88.60%4.91M
Operating profit
-33.15%-46.92M
-67.93%-69.81M
-25.65%-164.16M
-16.73%-46.57M
-150.51%-40.79M
-9.10%-35.24M
1.44%-41.57M
-194.42%-130.65M
-132.93%-39.9M
26.49%-16.28M
Net non-operating interest income expense
-9.12%6.64M
9.03%6.87M
162.08%29.22M
38.76%7.76M
79.46%7.86M
576.20%7.3M
6,327.55%6.3M
5,135.21%11.15M
10,862.75%5.59M
8,167.92%4.38M
Non-operating interest income
-9.12%6.64M
9.03%6.87M
162.08%29.22M
38.76%7.76M
79.46%7.86M
576.20%7.3M
6,327.55%6.3M
5,135.21%11.15M
10,862.75%5.59M
8,167.92%4.38M
Other net income (expense)
Income before tax
-44.20%-40.28M
-78.45%-62.94M
-12.92%-134.94M
-13.14%-38.82M
-176.67%-32.92M
10.52%-27.93M
16.18%-35.27M
-186.22%-119.5M
-128.30%-34.31M
46.14%-11.9M
Income tax
-3.19%243K
17.26%231K
128.36%1.02M
183.74%349K
105.77%221K
109.17%251K
197K
-120.63%-3.59M
-97.00%123K
-162.84%-3.83M
Net income
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
Net income continuous Operations
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
Minority interest income
Net income attributable to the parent company
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-43.78%-40.52M
-78.11%-63.17M
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
Basic earnings per share
-41.18%-0.48
-74.42%-0.75
-17.27%-1.63
-14.63%-0.47
-300.00%-0.4
10.53%-0.34
15.69%-0.43
-195.21%-1.39
-129.08%-0.41
70.59%-0.1
Diluted earnings per share
-41.18%-0.48
-74.42%-0.75
-17.27%-1.63
-14.63%-0.47
-300.00%-0.4
10.53%-0.34
15.69%-0.43
-201.46%-1.39
-130.60%-0.41
70.59%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 33.15%46.92M67.93%69.81M25.65%164.16M16.73%46.57M150.51%40.79M9.10%35.24M-1.44%41.57M-38.66%130.65M-43.80%39.9M-70.38%16.28M
Selling and administrative expenses -7.23%12.22M-3.04%12.23M2.47%49.92M-6.72%11.53M10.79%12.6M5.91%13.17M0.58%12.62M6.40%48.71M-6.29%12.36M-4.72%11.38M
-General and administrative expense -7.23%12.22M-3.04%12.23M2.47%49.92M-6.72%11.53M10.79%12.6M5.91%13.17M0.58%12.62M6.40%48.71M-6.29%12.36M-4.72%11.38M
Research and development costs 57.26%34.7M98.85%57.58M39.43%114.24M27.25%35.05M474.54%28.18M11.10%22.06M-2.29%28.95M-51.00%81.94M-52.36%27.54M-88.60%4.91M
Operating profit -33.15%-46.92M-67.93%-69.81M-25.65%-164.16M-16.73%-46.57M-150.51%-40.79M-9.10%-35.24M1.44%-41.57M-194.42%-130.65M-132.93%-39.9M26.49%-16.28M
Net non-operating interest income expense -9.12%6.64M9.03%6.87M162.08%29.22M38.76%7.76M79.46%7.86M576.20%7.3M6,327.55%6.3M5,135.21%11.15M10,862.75%5.59M8,167.92%4.38M
Non-operating interest income -9.12%6.64M9.03%6.87M162.08%29.22M38.76%7.76M79.46%7.86M576.20%7.3M6,327.55%6.3M5,135.21%11.15M10,862.75%5.59M8,167.92%4.38M
Other net income (expense)
Income before tax -44.20%-40.28M-78.45%-62.94M-12.92%-134.94M-13.14%-38.82M-176.67%-32.92M10.52%-27.93M16.18%-35.27M-186.22%-119.5M-128.30%-34.31M46.14%-11.9M
Income tax -3.19%243K17.26%231K128.36%1.02M183.74%349K105.77%221K109.17%251K197K-120.63%-3.59M-97.00%123K-162.84%-3.83M
Net income -43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M
Net income continuous Operations -43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M
Minority interest income
Net income attributable to the parent company -43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -43.78%-40.52M-78.11%-63.17M-17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M
Basic earnings per share -41.18%-0.48-74.42%-0.75-17.27%-1.63-14.63%-0.47-300.00%-0.410.53%-0.3415.69%-0.43-195.21%-1.39-129.08%-0.4170.59%-0.1
Diluted earnings per share -41.18%-0.48-74.42%-0.75-17.27%-1.63-14.63%-0.47-300.00%-0.410.53%-0.3415.69%-0.43-201.46%-1.39-130.60%-0.4170.59%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg